Function and goals
Review looks at daily benefit, remaining difficulty and whether treatment still supports the outcomes that matter to you.
ADHD needs can change with work, study, relationships, health and life stage. Review keeps support proportionate and prescribing clinically safe.
An ADHD assessment does not guarantee a diagnosis, medication, prescription or shared-care agreement. Please do not email medical details.

ADHD care should be careful enough to consider history, daily function, strengths, other possible explanations and the support needed next.
Review looks at daily benefit, remaining difficulty and whether treatment still supports the outcomes that matter to you.
Physical measures, appetite, sleep, mood, anxiety, substance use and other medicines are reviewed when relevant.
Responsibilities between specialist, patient, NHS GP and pharmacy stay explicit, including when shared care changes.
The clinician brings together the person’s account, reliable supporting information, clinical expertise and recognised diagnostic and treatment standards.
The aim is an accurate, useful formulation—not a predetermined outcome.
Consider attention, impulsivity, restlessness, emotional regulation and functioning across key settings.
Provide measurements and other safety information at the intervals specified by the clinician and applicable guidance.
Discuss pregnancy, new health conditions, other medicines, driving, work risks, travel and changes in substance use.
Reconsider overall need, medicine, dose, adverse effects, preferences, non-medication support and future monitoring.
Good preparation reduces delay, protects confidentiality and makes the clinical discussion more useful.
Each stage should explain what is needed, who is responsible and what remains subject to clinical review.
Track benefit, function, adverse effects and requested measurements.
Discuss clinical progress and material changes with the responsible clinician.
Continue, change or stop treatment only through an agreed plan.
Confirm prescribing, monitoring and the next specialist review.
Clear expectations matter before assessment, treatment or transfer of care.
The clinician sets the schedule according to treatment stage, age, medicine, risk and current guidance. Titration usually needs closer contact than stable maintenance.
Some ADHD medicines can affect pulse, blood pressure, appetite or weight. Monitoring supports a safer decision about ongoing treatment.
Some reviews may be suitable remotely if reliable information is available. The clinician may require in-person examination or measurements.
Tell the responsible clinician. Some medicines should not be changed or restarted without advice, and the reasons for stopping may affect the next plan.
Contact the specialist service promptly. Do not assume either service has automatically taken over; responsibility and a safe supply plan must be clarified.
Email your name, contact details and whether the enquiry concerns an adult or a child or young person. Please do not include symptoms, reports, medicines or other medical information in ordinary email; the team will explain the secure clinical route.
Eligibility, clinician, process, current fees and continuing-care scope are confirmed before payment.